Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 553

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 553
---
 all amendments, terminations and modifications thereof or waivers thereto.

“ Liability ” or “ Liabilities ” means any and all debts, liabilities and obligations, whether accrued or fixed, known or unknown, absolute or contingent, matured or unmatured or determined or determinable.

<div align='center'>A-7</div>

TABLE OF CONTENTS

“ Licensed Intellectual Property ” means all Intellectual Property that (i) is the subject of any agreement granting or purporting to grant a license or any other rights to the Company or its Affiliates, whether directly or indirectly, e.g., via the grant of a sublicense or (ii) is purported by the Company to be licensed to it or otherwise available for its use in the development and commercialization of Products, including the InnoBation License, the TDT License and the Viral Gene License.

“ Liens ” means, with respect to any specified asset, property or security, any and all liens, mortgages, charges, hypothecations, claims, encumbrances, options, pledges, licenses, rights of priority, easements, covenants, restrictions and security interests thereon, rights of first refusal, option, proxy, voting trust, restriction (whether on voting, sale, transfer, disposition or otherwise), any subordination arrangement in favor of another Person, or any filing or agreement to file a financing statement as debtor under the Uniform Commercial Code or any similar Law.

“ Liminatus Merger Sub ” has the meaning set forth in the Preamble.

“ Liminatus Merger Sub Common Stock ” has the meaning set forth in Section 5.5(h) .

“ Loan Agreement ” has the meaning set forth in Section 4.1(b)(x) .

“ Lock-Up Agreements ” has the meaning set forth in the Recitals hereto.

“ Lookback Date ” means the date of organization of the Company.

“ LTIP ” has the meaning set forth in Section 8.4 .

“ Material Adverse Effect ” means, any change, event, circumstance, occurrence, effect, development or state of facts that, individually or in the aggregate, with any other change, event, circumstance, occurrence, effect, development or state of facts has had or would reasonably be expected to have either (a) a material adverse effect on the business, assets, liabilities, operations, results of operations or condition (financial or otherwise) of the Company or (b) prevent or materially delay or materially impact the ability of the Company to